ClinicalTrials.gov
public full text
Public Domain
Beta Cell Function and Related Pharmacodynamics of HMS5552 in T2DM Patients
This study evaluates the beta cell function, pharmacodynamics, pharmacokinetics, safety and tolerability after 4 weeks treatment of 75mgBID or 75mgQD of HMS5552.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Long-term Efficacy and Safety of HMS5552 add-on to Metformin in T2DM Subjects#261478
- A Clinical Trial of MT200605 for the Treatment of Acute Ischemic Stroke#1095396
- Astroglial Dysfunction in Models of CDKL5 Deficiency Disorder#353172
- Effects of Different Early Intensive Therapies on Long-term β-cell Function#249562
- Metoprolol and Formoterol in Chronic Obstructive Pulmonary Disease (COPD)#883221
Record · ID 1089100
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive